Danske Bank A/s »

Atrium Therapeutics shares owned by Danske Bank A/s

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2026-03-31 $280 21 13.35

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Berkshire Hathaway Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Danske Bank A/s

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics